Overview

The Repatriation Medical Authority Instrument No. 46 of 2011 amends Statement of Principles Instrument No. 38 of 2006 concerning myelodysplastic disorder. This legislative instrument was enacted to address gaps and problems in the recognition and treatment of myelodysplastic disorder in the context of veterans' entitlements. The Veterans' Entitlements Act 1986, administered by the Australian Parliament, provides the legislative framework for this instrument. The overarching policy objective is to ensure that veterans and their dependants receive appropriate medical recognition and compensation for conditions linked to their service, including myelodysplastic disorder. The Authority's investigation and subsequent determination aim to refine the criteria for entitlement, ensuring that the amendments are both accurate and reflective of current medical understanding.

Scope and Application

The Repatriation Medical Authority Instrument No. 46 of 2011 amends Statement of Principles Instrument No. 38 of 2006 concerning myelodysplastic disorder under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. This legislative instrument applies to veterans and their dependants who may have sustained myelodysplastic disorder through specific medical treatments or exposure to ionising radiation. The changes made by this Instrument involve replacing existing factors and definitions related to certain treatments and exposure, as well as deleting outdated definitions. The amendments are effective as specified in accordance with the Legislative Instruments Act 2003. The Authority's investigation into the condition was advertised in the Government Notices Gazettes, inviting submissions from relevant parties, although none were received. This Instrument concludes the investigation and the revised Statement of Principles is now in effect, with references available upon request to the Repatriation Medical Authority.

Key Provisions

The Repatriation Medical Authority Instrument No. 46 of 2011 amends the Statement of Principles Instrument No. 38 of 2006 concerning myelodysplastic disorder under the Veterans’ Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004. This amendment, made under subsection 196B(3) and (8) of the VEA, replaces certain factors related to the disorder with new ones concerning 'ionising radiation', 'treatment with radioactive iodine', and 'treatment with radioactive phosphorous' (sections 2 and 3). Additionally, it revises the definition of "cumulative equivalent dose" and removes the definitions of "a course of therapeutic radiation" and "atomic radiation" from clause 9 (section 2). The Instrument sets a specific date of effect in line with subsection 12(1)(a) of the Legislative Instruments Act 2003 (section 3). The Repatriation Medical Authority conducted an investigation into myelodysplastic disorder, as advertised in the Government Notices Gazettes on 1 September 2010 and 3 November 2010. The Authority invited submissions from relevant organisations and experts but received none. This Instrument concludes the investigation and formalises the changes to the Statement of Principles, which will now reflect the updated understanding of the disorder’s causes and contributing factors (sections 4 and 5). Interested parties can request a list of references related to the condition by writing to the Repatriation Medical Authority at the specified address (section 6). The amendments impose certain obligations on parties governed by the VEA and the Military Rehabilitation and Compensation Act 2004. These include adhering to the new definitions and factors concerning myelodysplastic disorder, ensuring that any claims or assessments are made in accordance with the updated Statement of Principles. This may require veterans and their representatives to provide updated medical evidence and documentation that aligns with the new criteria (section 2). There are no explicit offences, penalties, or civil/criminal consequences detailed within the Instrument itself. However, any failure to comply with the updated Statement of Principles when making claims or assessments could potentially lead to disputes or denials of benefits. Such outcomes would depend on the individual circumstances of each case and the evidence presented, rather than specific statutory penalties outlined in the Instrument (section 6).